Incorporating the patient perspective in the study of rare bone disease: insights from the osteogenesis imperfecta community
- PMID: 30191258
- PMCID: PMC6449303
- DOI: 10.1007/s00198-018-4690-7
Incorporating the patient perspective in the study of rare bone disease: insights from the osteogenesis imperfecta community
Abstract
There is limited research which examines health concerns of individuals with osteogenesis imperfecta (OI). Discussion groups with leaders of the adult OI community identified a broad range of medical priorities beyond fractures and brittle bones. Our work underscores the need to include patient-reported outcomes in rare bone disease research.
Introduction: Osteogenesis imperfecta (OI) is a rare genetic disorder affecting collagen protein leading to brittle bones and a number of other medical complications. To date, there is limited research which examines the life-long process of aging with this rare disease, much less the perspective of individuals with OI.
Methods: In order to explore and prioritize health concerns that adults with OI feel have been inadequately addressed in health care and research, investigators held discussions with leaders from the global adult OI community. The meetings were held in August 2017 at the 13th International Conference on OI in Oslo, Norway as part of the preconference seminar "Patient Participation in OI Research". Investigators were part of the Brittle Bone Disease Consortium (BBDC), a multicenter research program devoted to the study of OI, and their focus was on patient-reported outcomes (PRO).
Results: Participants noted that while fractures and brittle bones are the most common feature of OI, a number of body systems are under-studied in this disorder. They particularly emphasized breathing, hearing, and the effects of aging as primary concerns that researchers and physicians may not fully understand or address. Other areas included pain, gastrointestinal problems, mental health, nutrition, menopause/pregnancy, and basilar invagination. Participants also emphasized that they must be informed of study results. They underscored that outcome measures incorporated into future drug trials must look beyond fractures and consider the whole patient.
Conclusions: This work will help guide the incorporation of PROs into the next phase of the BBDC Natural History Study of OI and underscores the importance of including PROs in the study of rare diseases.
Keywords: Community-based participatory researchimperfecta; Osteogenesis; Patient perspective; Patient reported outcome measures; Quality of Life (QoL); Rare bone disease.
Conflict of interest statement
Conflict of interest
Tracy S. Hart serves as the CEO of the Osteogenesis Imperfeta Foundation. We do not believe that this represents a conflict of interest. As noted in her conflict of interest disclosure, Teresa Swezey received travel funds to attend the OI conference. Bryce B. Reeve, Marianne K. Floor, Christina M. Dollar, Austin P. Gillies, and Laura L. Tosi declare that they have no disclosures.
Similar articles
-
Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study.Orphanet J Rare Dis. 2019 Jan 29;14(1):23. doi: 10.1186/s13023-019-1004-x. Orphanet J Rare Dis. 2019. PMID: 30696467 Free PMC article.
-
Health-related quality of life in children with osteogenesis imperfecta: a large-sample study.Osteoporos Int. 2019 Feb;30(2):461-468. doi: 10.1007/s00198-018-4801-5. Epub 2018 Dec 19. Osteoporos Int. 2019. PMID: 30569229
-
Quality of life in osteogenesis imperfecta: A mixed-methods systematic review.Am J Med Genet A. 2016 Jan;170A(1):62-76. doi: 10.1002/ajmg.a.37377. Epub 2015 Sep 14. Am J Med Genet A. 2016. PMID: 26365089 Review.
-
Osteogenesis imperfecta and the teeth, eyes, and ears-a study of non-skeletal phenotypes in adults.Osteoporos Int. 2018 Dec;29(12):2781-2789. doi: 10.1007/s00198-018-4663-x. Epub 2018 Aug 24. Osteoporos Int. 2018. PMID: 30143849
-
Clinical manifestations of osteogenesis imperfecta in adulthood: An integrative review of quantitative studies and case reports.Am J Med Genet A. 2020 Apr;182(4):842-865. doi: 10.1002/ajmg.a.61497. Epub 2020 Feb 24. Am J Med Genet A. 2020. PMID: 32091187 Review.
Cited by
-
Optimising Health-Related Quality of Life in Children With Osteogenesis Imperfecta.Calcif Tissue Int. 2024 May 2. doi: 10.1007/s00223-024-01205-4. Online ahead of print. Calcif Tissue Int. 2024. PMID: 38695871 Review.
-
Access to care among patients with osteogenesis imperfecta during the COVID-19 pandemic.Arch Osteoporos. 2023 Nov 28;18(1):143. doi: 10.1007/s11657-023-01355-2. Arch Osteoporos. 2023. PMID: 38015270 Free PMC article.
-
"Osteogenesis Imperfecta Patients Wish Orthopedic Surgeons Had Better Strategies to Help with…"-Results of a Patient and Parent-Oriented Survey.Children (Basel). 2023 Aug 4;10(8):1345. doi: 10.3390/children10081345. Children (Basel). 2023. PMID: 37628344 Free PMC article.
-
Systematic review of health related-quality of life in adults with osteogenesis imperfecta.Orphanet J Rare Dis. 2023 Feb 22;18(1):36. doi: 10.1186/s13023-023-02643-3. Orphanet J Rare Dis. 2023. PMID: 36814291 Free PMC article.
-
The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review.Orphanet J Rare Dis. 2023 Feb 22;18(1):34. doi: 10.1186/s13023-023-02627-3. Orphanet J Rare Dis. 2023. PMID: 36814274 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
